key: cord-0733304-1i4xmbuf
authors: Moon, Rena C; Mackey, Rachel H; Cao, Zhun; Emont, Seth; Schott, Laura L; Gayle, Julie; Lipkin, Craig; Rosenthal, Ning
title: Is COVID-19 Less Deadly Now? -- Trends of In-Hospital Mortality Among Hospitalized COVID-19 Patients in the United States
date: 2021-09-17
journal: Clin Infect Dis
DOI: 10.1093/cid/ciab830
sha: 1ad827b07bd16999a98f1f18a96a792bb77cfbcb
doc_id: 733304
cord_uid: 1i4xmbuf

After an initial decline from April through June 2020 (from 22.2% to 11.9%), adjusted in-hospital mortality in COVID-19 inpatients peaked twice and was significantly higher than June 2020 for subsequent months except in July and October 2020. Adjusted mortality trends differed across age groups between November 2020 and February 2021.

As of August, 2021, coronavirus disease 2019 has contributed to over 624,000 deaths in the United States (U.S.). 1 During the early months of the pandemic (April to June of 2020), a sharp decrease in in-hospital mortality was widely reported. 2, 3 Monthly crude in-hospital mortality among confirmed COVID-19 inpatients has been estimated using a geographically diverse all-payer hospital administrative database (Premier Healthcare Database [PHD] ) that accounts for about 20-25% of total inpatient encounters in the U.S. at the Centers for Disease Control and Prevention (CDC) COVID Data Tracker site (https://covid.cdc.gov/covid-data-tracker/#hospitalizations-severity). Although such information is helpful to the public, crude mortality may not reflect true changes in mortality associated with shift in patient demographics, clinical and hospital characteristics during the pandemic. 2, [4] [5] [6] Since both patient and hospital factors can affect mortality among COVID-19 inpatients, it is important to know whether differences in these factors explain any of the observed changes in mortality over the course of the pandemic. [7] [8] [9] [10] This study aimed to describe covariate-adjusted monthly trends in overall, age-, and sex-specific in-hospital mortality among U.S. COVID-19 inpatients from April 2020 through February 2021 during both initial encounter and 30-day followup.

We performed a retrospective cohort study using the Premier Healthcare Database COVID-19 special release (PHD-SR), 9, 11 a standalone version of PHD from January 1, 2019 to the most current data available to accommodate urgent COVID-19 research needs. The PHD-SR contains data from approximately 800+ hospitals and is currently used by the National Institute of Health (NIH) and CDC for COVID-19-related studies. 5, 12, 13 A c c e p t e d M a n u s c r i p t 4 All data were statistically deidentified and compliant with the Health Insurance Portability and Accountability Act. Based on US Title 45 Code of Federal Regulations, Part 46, the study was exempted from institutional review board approval. The study followed the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) 14 reporting guideline.

All COVID-19-related inpatient discharges between April 1, 2020 and February 28, 2021 with a principal/secondary discharge diagnosis of COVID-19 (International Classification of Diseases, 10 th revision, Clinical Modification [ICD-10-CM] diagnosis code U07.1) were analyzed. 15 To avoid variation over time in hospitals submitting data to PHD-SR, we only included visits from hospitals that continuously submitted data during the study period.

The primary outcome was 'in-hospital mortality' (discharge status equal to "expired") during the "index hospitalization" (first COVID-19-related inpatient admission during the study period) or subsequent COVID-19-related inpatient or outpatient visits to the same hospital within 30 days of discharge.

Patient demographic and clinical characteristics assessed at the index hospitalization included age, sex, self-reported race and ethnicity, primary insurance payer, and comorbidities. Hospital characteristics included urbanicity of population served (i.e., urban or rural), teaching status, U.S. census region (i.e., Midwest, Northeast, South, or West), and bed size (i.e., 1-299, 300-499, 500+ beds). Two separate fields for race and ethnicity were combined into one race/ethnicity field and categorized as Hispanic, white, black, or other/unknown.

Comorbidities, including hypertension, history of smoking, morbid obesity, and comorbidities included in the Charlson-Deyo Comorbidity Index (CCI) 16 were identified using ICD-10-CM discharge diagnosis codes (Supplement eTable 1) during index hospitalization or any prior visit to the same hospital within 180 days. Weighted CCI score was grouped into three categories: 0, 1-4, and 5+.

A c c e p t e d M a n u s c r i p t 5

Unadjusted in-hospital mortality was calculated as the proportion of hospitalized patients who died either during index hospitalization or within 30 days of discharge for each month. Adjusted odds of in-hospital mortality by month were assessed using multivariable logistic regression models with mortality as outcome and discharge month as predictor (the lowest point of mortality during study period, June 2020, was used as reference month). A priori covariates included patient characteristics (sex, age group, race/ethnicity, comorbidities) and hospital characteristics (urban/rural population served, teaching status, geographical region, size). Final model covariates were selected using a backward selection method, with a significance level of p < .10 for covariates to stay in the model and robust standard errors to adjust for clustering of patients within hospitals. Based on the variance inflation factor, covariate multicollinearity was not present in the final model. Lastly, covariate-adjusted in-hospital mortality was estimated using the recycled prediction method to calculate predicted margins. [17] [18] [19] [20] Age-and sex-specific results were calculated using the same methods and covariates, except excluding age (for age-specific), or sex (for sex-specific).

All analyses were performed using SAS version 9.4 (SAS Institute Inc., Cary, North Carolina), and the figures were generated using R version 4.0.2 (R Foundation for Statistical Computing, Vienna, Austria).

A total of 528,620 adult patients with one or more COVID-19-related inpatient discharges from 876 hospitals between April 2020 and February 2021 were identified in the PHD-SR. Of these patients, 58,527 were excluded due to non-continuous hospital data submission, leaving 470,093 patients from 508 hospitals in the final study cohort. Excluded patients were more likely to be hospitalized in small (1-299 beds, 66.9% vs. 35.5%), non-teaching (67.9% vs. 51.7%), and rural hospitals (33.3% vs.

A c c e p t e d M a n u s c r i p t 6

The average age of the study population was 63.9 years, 51.7% were male; 53.4% were white, 18%

were black, and 18% were Hispanic (Table 1) . Common comorbidities were hypertension (69.9%), diabetes mellitus (42.3%), chronic pulmonary disease (23.6%), and morbid obesity (21.5%) ( Table 1, Supplement eFigure 1). Most patients (46.1%) were hospitalized in the South (reflective of hospitals included in PHD) and in urban hospitals (90.2%), but patients were evenly distributed across small, medium, and large hospitals.

Trends in mortality were very similar before and after adjusting for significant patient and hospital characteristics (sex, age group, race/ethnicity, CCI score category, morbid obesity, hypertension, chronic kidney disease, diabetes mellitus, hospital urban/rural population served, teaching status, geographical region, bed size) (Figure 1a , Supplement eFigure 2 and eTable 2). From the initial high of 22.2% in April 2020, in-hospital mortality declined to 11.9% by June 2020 but showed no further decline through February 2021. Instead, in-hospital mortality showed two peaks between July 2020 and February 2021 -increasing to 14.0% in August 2020 (p<.01 vs. June 2020) and decreasing to 12.2% in October 2020 (12.2%, p = .36), and then increasing again to 14.1% in January 2021 (p<.01).

Relative to June 2020, the month with the lowest mortality, the odds of in-hospital mortality were significantly higher (by about 20%) in August, September, and December of 2020, and January and February of 2021 (adjusted odds ratio [ a OR]: 1.23, 1.17, 1.21, 1.24, 1.21, respectively).

We also evaluated age-specific and sex-specific monthly trends in in-hospital mortality. In 85+ years old patients, adjusted mortality significantly increased from June to July 2020 (19.2% to 23.6%, p<.01) and decreased from December 2020 to February 2021 (from 24.4% to 21.0%, p<.01) ( showed that for both men and women, in-hospital mortality was higher in August and September 2020, and again in November 2020 through February 2021 than in June 2020.

Using a national database, this study provides covariate-adjusted monthly trends in in-hospital mortality of COVID-19 inpatients from April 2020 through February 2021. Like prior reports, 2,3 our study demonstrated that overall in-hospital mortality decreased approximately by half from 22.2% to 11.9% between April and June of 2020. We extended the observation period and showed that from July 2020 through February 2021, there was no further decline, and instead, adjusted inhospital mortality peaked twice and was significantly higher in all months except July and October 2020 compared to June 2020. Our results are congruent with but extend the analytics posted by the CDC COVID tracker using the same database by including 30-day follow-up, requiring continuous data submission by hospitals, and adjusting for differences in important hospital and patient characteristics across time.

The explanation for persistently high in-hospital mortality among COVID-19 inpatients is not clear.

However, the peaks may be due at least in part to overcrowding in hospitals when cases surge. Kadri et al. 5 found that between March and August 2020, surges in hospital COVID-19 caseload possibly eroded benefits gained from better treatments. Our study supports these findings by showing that both the total number of deaths and adjusted in-hospital mortality peaked again between December 2020 and February 2021, when cases were surging.

COVID-19 Dashboard by the

Variation in US Hospital Mortality Rates for Patients Admitted With COVID-19 During the First 6 Months of the Pandemic

Trends in COVID-19 Risk-Adjusted Mortality Rates

Trends in COVID-19-related inhospital mortality: lessons learned from nationwide samples

Association Between Caseload Surge and COVID-19 Survival in 558 U.S. Hospitals

Treatment journey of COVID-19 patients in hospital settings

Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study

Preliminary Estimates of the Prevalence of Selected Underlying Health Conditions Among Patients with Coronavirus Disease 2019 -United States

Risk Factors Associated With In-Hospital Mortality in a US National Sample of Patients With COVID-19

Association of Intensive Care Unit Patient Load and Demand With Mortality Rates in US Department of Veterans Affairs Hospitals During the COVID-19 Pandemic

Premier Healthcare Database (COVID-19): Data that informs and performs

Patients Discharged and Experiencing Same-Hospital Readmission -United States

Body Mass Index and Risk for COVID-19-Related Hospitalization, Intensive Care Unit Admission, Invasive Mechanical Ventilation, and Death -United States

The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies

CDC. ICD-10-CM official coding and reporting guidelines

Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases

Using "Recycled Predictions" for Computing Marginal Effects

Estimating marginal and incremental effects on health outcomes using flexible link and variance function models

Trends in Obesity Among Adults in the United States

Trends in Racial and Ethnic Disparities in COVID-19 Hospitalizations, by Region -United States

Metastatic Solid Tumor 6174 (1.3%) 1456 (2.1%) HIV Disease

Teaching Hospital 227100 (48.3%) 34897 (51.3%) Urbanicity of Population Served, n (%) Rural

* If the patient self-reported Hispanic ethnicity, the patient was categorized as Hispanic. Patients with ethnicity as 'not Hispanic or unknown' were categorized using race

A c c e p t e d M a n u s c r i p t A c c e p t e d M a n u s c r i p t 12 footnote: *Adjusted for month, sex, age group, race/ethnicity, Charlson Comorbidity Index score category, morbid obesity, hypertension, chronic kidney disease, diabetes mellitus, hospital size, hospital teaching status, hospital region, and urbanicity of population served * Age and sex were not included in the model for age-specific and sex-specific results, respectively.A c c e p t e d M a n u s c r i p t 15 Figure 1